Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever.


Journal

Cellular immunology
ISSN: 1090-2163
Titre abrégé: Cell Immunol
Pays: Netherlands
ID NLM: 1246405

Informations de publication

Date de publication:
08 2022
Historique:
received: 07 04 2022
revised: 15 06 2022
accepted: 16 06 2022
pubmed: 1 7 2022
medline: 10 8 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

We have previously demonstrated that Mucosal-Associated Invariant T (MAIT) cells secrete multiple cytokines after exposure to Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever in humans. However, whether cytokine secreting MAIT cells can enhance or attenuate the clinical severity of bacterial infections remain debatable. This study characterizes human MAIT cell functions in subjects participating in a wild-type S. Typhi human challenge model. Here, we found that MAIT cells exhibit distinct functional signatures associated with protection against typhoid fever. We also observed that the cytokine patterns of MAIT cell responses, rather than the average number of cytokines expressed, are more predictive of typhoid fever outcomes. These results might enable us to objectively, based on functional parameters, identify cytokine patterns that may serve as predictive biomarkers during natural infection and vaccination.

Identifiants

pubmed: 35772315
pii: S0008-8749(22)00097-1
doi: 10.1016/j.cellimm.2022.104572
pmc: PMC9377420
mid: NIHMS1822276
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104572

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI142725
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007524
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082655
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109776
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI036525
Pays : United States
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Clin Vaccine Immunol. 2010 Sep;17(9):1305-14
pubmed: 20660136
Trans R Soc Trop Med Hyg. 1980;74(5):553-6
pubmed: 7210105
Annu Rev Immunol. 2020 Apr 26;38:203-228
pubmed: 31986071
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34615705
Clin Infect Dis. 2014 May;58(9):1230-40
pubmed: 24519873
Lancet. 2017 Dec 2;390(10111):2419-2421
pubmed: 28965714
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3119-28
pubmed: 23898209
Trends Microbiol. 2006 Dec;14(12):536-42
pubmed: 17055276
Int Dig Health Legis. 1997;48(2):231-4
pubmed: 11656783
Front Immunol. 2015 Sep 17;6:466
pubmed: 26441971
Front Immunol. 2015 Feb 02;6:27
pubmed: 25699045
J Transl Med. 2016 Mar 01;14:62
pubmed: 26928826
Front Immunol. 2014 Jan 07;4:511
pubmed: 24432025
Front Immunol. 2017 Mar 02;8:208
pubmed: 28303138
Lancet. 2021 Aug 21;398(10301):675-684
pubmed: 34384540
PLoS One. 2012;7(6):e38408
pubmed: 22679502
Semin Nucl Med. 1978 Oct;8(4):283-98
pubmed: 112681
Elife. 2020 Nov 09;9:
pubmed: 33164745
Scand J Immunol. 2014 Oct;80(4):271-5
pubmed: 24846411
Nat Commun. 2020 Jul 24;11(1):3755
pubmed: 32709874
N Engl J Med. 1970 Sep 24;283(13):686-91
pubmed: 4916913
Sci Rep. 2020 Aug 12;10(1):13581
pubmed: 32788681
Front Immunol. 2017 Apr 06;8:398
pubmed: 28428786
Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25923-25931
pubmed: 31772015
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74
pubmed: 24367114
Front Immunol. 2021 Oct 01;12:728685
pubmed: 34659215
Retrovirology. 2008 Jul 16;5:64
pubmed: 18631400
JCI Insight. 2021 Mar 8;6(5):
pubmed: 33561009
Inflamm Bowel Dis. 2015 Jul;21(7):1529-40
pubmed: 25946569
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Clin Chem. 1993 Apr;39(4):561-77
pubmed: 8472349
J Infect Dis. 1977 Dec;136(6):717-23
pubmed: 925379
Intensive Care Med. 2014 Feb;40(2):192-201
pubmed: 24322275
Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S6-8
pubmed: 17582572
Clin Transl Immunology. 2021 Jan 19;10(1):e1239
pubmed: 33505681
N Engl J Med. 2002 Nov 21;347(21):1652-61
pubmed: 12444179
J Immunol. 2002 Aug 15;169(4):2196-203
pubmed: 12165550
Exp Gerontol. 2014 Jan;49:47-54
pubmed: 24269212
Clin Exp Immunol. 2014 May;176(2):266-74
pubmed: 24450998
CJEM. 2006 Jan;8(1):19-20
pubmed: 17175625
PLoS Negl Trop Dis. 2019 Aug 14;13(8):e0007650
pubmed: 31412039

Auteurs

Rosângela Salerno-Gonçalves (R)

Center for Vaccine Development & Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: rmezghan@som.umaryland.edu.

Stephanie Fresnay (S)

Center for Vaccine Development & Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Laurence Magder (L)

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Thomas C Darton (TC)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.

Claire S Waddington (CS)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.

Christoph J Blohmke (CJ)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.

Brian Angus (B)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.

Myron M Levine (MM)

Center for Vaccine Development & Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Andrew J Pollard (AJ)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK.

Marcelo B Sztein (MB)

Center for Vaccine Development & Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH